Cargando…
A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease
The atypical antipsychotic ziprasidone has been considered inappropriate for use in patients with Parkinson’s disease (PD), as most atypical antipsychotics worsen parkinsonism. However, the current evidence for safety and efficacy of ziprasidone in PDP has not been evaluated in a systematic fashion....
Autores principales: | Younce, John R., Davis, Albert A., Black, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398550/ https://www.ncbi.nlm.nih.gov/pubmed/30475775 http://dx.doi.org/10.3233/JPD-181448 |
Ejemplares similares
-
A Case Report of Priapism Caused by Ziprasidon
por: Karamustafalioglu, Nesrin, et al.
Publicado: (2013) -
Case Report: Ziprasidone induced neuroleptic malignant syndrome
por: Sedhai, Yub Raj, et al.
Publicado: (2021) -
Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021) -
Ziprasidone in the Treatment of Delusional Parasitosis
por: Contreras-Ferrer, P., et al.
Publicado: (2012) -
Ziprasidone and its Association with Sudden Cardiac Death - A Case Report
por: Sidana, Ajeet, et al.
Publicado: (2004)